方法对75例慢性乙型肝炎患者(其中偏实证组30例,偏虚证组45例)采用基质显色法检测血浆内毒素(endotoxin, ET)水平,以同期健康体检正常者15名作对照.并对其中20例患者行肝组织活检.
基于4个网页-相关网页
...学》2008年07期 ipenem,IPM)、头孢派酮(Ce-foperazone,CPZ)治疗,于用药前、后抽取静脉血,检测血浆内毒素(Lipopolysaccharide,LPS)及IL-6水平,分析其变化规律。
基于1个网页-相关网页
...带医学》2008年07期 ipenem,IPM)、头孢派酮(Ce-foperazone,CPZ)治疗,于用药前、后抽取静脉血,检测血浆内毒素(Lipopolysaccharide,LPS)及IL-6水平,分析其变化规律。
基于1个网页-相关网页
动态观察最初三天血浆PCT的变化对不同结局的预测性及临床疗效的指导性优于内毒素检测。
Dynastic observe the variation of plasma PCT in the first three days was superior to endotoxin in the predictability to different outcome and the guidance of clinical treatment.
方法：对39例慢性乙肝患者与2 0例正常人血浆内毒素、一氧化氮、T细胞亚群及IL 2的含量进行检测。
Methods:We detected plasma endotoxin, NO, T lymphocyte subgroups and IL-2 in 39 patients with chronic hepatitis B and 20 healthy subjects.
本文采用鲎变形细胞溶解物(LAL)改良基质显色法对91例肝脏病患者和20例健康对照血浆内毒素进行定量检测。
The plasma endotoxin levels of 91 hepatopaths and 20 healthy controls were detected by using a quantitative endotoxin assay of limulus amoebocyte lysate (LAL) test with a chromogenic substrate.
应用推荐